Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc

AUPH · NASDAQ
AUPH · NASDAQ
14.99
USD0.010.07%

Latest News

    SeekingAlpha

    Aurinia Pharmaceuticals acquiring Kezar Life Sciences

      SeekingAlpha

      Aurinia Pharmaceuticals gains as two board members resign amid holder vote

        @eWhispers
        eWhispers

        #earnings before the open tomorrow https://t.co/lObOE0dgsr $MRNA $RCL $DDOG $BUD $PTON $W $NVO $COP $PARA $SHEL $PLNT $K $RACE $REGN $PENN $CG $CAH $H $ATI $AUYTL $LNTH $PZZA $ARGX $ZTS $DINO $SHAK $AUPH $BHC $STWD $TGLS $BWA $PCG $SWK $FOUR $AG $PRVA $AEP $NFE $EQNR $PH $CMRX… https://t.co/ZdNHGu9zTe

          SeekingAlpha

          Aurinia Pharmaceuticals gains amid renewed takeover speculation

            SeekingAlpha

            Aurinia Pharmaceuticals gains amid M&A speculation following patent settlement

              SeekingAlpha

              Aurinia Pharmaceuticals gains on speculation of Otsuka bid

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              14.36USD
              15.26USD

              52 Week Range

              8.84USD
              19.25USD

              Market Cap

              1.92BUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              CA05156V1022

              CUSIP

              05156V102

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              7.03

              PEG Ratio

              -

              Book Value

              4.34

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              2.16

              Wall Street Target Price

              17.00

              EPS Estimate Current Year

              0.95

              EPS Estimate Next Year

              1.11

              EPS Estimate Current Quarter

              0.1975

              EPS Estimate Next Quarter

              0.2033

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              298,295,008

              Gross Profit TTM

              233,467,008

              EBITDA

              153,712,000

              Profit Margin

              99.97%

              Return On Assets TTM

              13.66%

              Return On Equity TTM

              64.98%

              Revenue Per Share TTM

              2.247

              Qtly Revenue Growth YOY

              24.40%

              Diluted Eps TTM

              2.16

              Qtly Earnings Growth YOY

              56.30%

              Valuation

              Trailing PE

              7.03

              Forward PE

              17

              Price Sales TTM

              6.5444

              Price Book MRQ

              3.3893

              Enterprise Value Revenue

              5

              Enterprise Value EBITDA

              10

              Peers analysis

              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                760.00

                3.03%
              • CSL Ltd
                CSLLYCSL Ltd

                22.75

                2.52%
              • argenx SE
                ARGNFargenx SE

                865.00

                0.00%
              • CSL Limited
                CMXHFCSL Limited

                88.94

                0.00%
              • UCB SA ADR
                UCBJYUCB SA ADR

                124.85

                -12.62%
              • UCB SA
                UCBJFUCB SA

                259.59

                -12.18%
              • argenx NV ADR
                ARGXargenx NV ADR

                853.82

                -2.26%
              • Revolution Medicines Inc
                RVMDRevolution Medicines Inc

                187.48

                -2.14%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                476.99

                -0.98%
              • Alnylam Pharmaceuticals Inc
                ALNYAlnylam Pharmaceuticals Inc

                204.11

                -0.83%
              XM

              Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

              Trade with a Trusted, Award-Winning Broker.

              Trading involves risk. The value of investments may go up or down. Trade responsibly.

              FAQs

              What is Aurinia Pharmaceuticals stock price today?

              What is Aurinia Pharmaceuticals stock ticker?

              Is AUPH stock price going up?

              What is the analyst recommendation for AUPH?

              What is AUPH market cap?

              Does AUPH release financial reports?

              When is AUPH next earnings date?

              What were AUPH Earnings for the last quarter?

              What was AUPH Revenue for the last quarter?

              What was AUPH Net Income for the last quarter?

              Does AUPH pay dividends?

              How many employees does AUPH have?

              What is AUPH EBITDA?

              How to buy AUPH stocks?

              Should I invest in AUPH stock?